These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6383918)

  • 1. Effects of insulin antibodies on bioavailability of insulin: preliminary studies using 123I-insulin in patients with insulin-dependent diabetes.
    Sodoyez JC; Sodoyez-Goffaux F
    Diabetologia; 1984 Jul; 27 Suppl():143-5. PubMed ID: 6383918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differing effects of antiinsulin serum and antiinsulin receptor serum on 123I-insulin metabolism in rats.
    Sodoyez JC; Sodoyez Goffaux F; von Frenckell R; De Vos CJ; Treves S; Kahn CR
    J Clin Invest; 1985 May; 75(5):1455-62. PubMed ID: 3889055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered insulin distribution and metabolism in type I diabetics assessed by [123I]insulin scanning.
    Hachiya HL; Treves ST; Kahn CR; Sodoyez JC; Sodoyez-Goffaux F
    J Clin Endocrinol Metab; 1987 Apr; 64(4):801-8. PubMed ID: 3546355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of isologous and autologous insulin antibodies on in vivo bioavailability and metabolic fate of immune-complexed insulin in Lou/M rats.
    Arquilla ER; McDougall BR; Stenger DP
    Diabetes; 1989 Mar; 38(3):343-9. PubMed ID: 2645191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of insulin antibodies on pharmacokinetics and bioavailability of recombinant human and highly purified beef insulins in insulin dependent diabetics.
    Gray RS; Cowan P; di Mario U; Elton RA; Clarke BF; Duncan LJ
    Br Med J (Clin Res Ed); 1985 Jun; 290(6483):1687-91. PubMed ID: 3924216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin receptor antibodies inhibit insulin uptake by the liver: in vivo 123I-insulin scintigraphic scanning and in vitro characterization in autoimmune hypoglycemia.
    Dozio N; Sarugeri E; Scavini M; Beretta A; Belloni C; Dosio F; Savi A; Fazio F; Sodoyez-Goffaux F; Pozza G
    J Investig Med; 2001 Jan; 49(1):85-92. PubMed ID: 11217151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solid versus liquid phase assays in detection of insulin antibodies. Influence of iodination site on labelled insulin binding.
    Stumpo RR; Llera AS; Cardoso AI; Poskus E
    J Immunol Methods; 1994 Mar; 169(2):241-9. PubMed ID: 8133083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo kinetics of 123I-labelled insulin: studies in normal subjects and patients with diabetes mellitus.
    Sinclair AJ; Signore A; Bomanji J; Britton KE; Pozzilli P; Gale EA
    Nucl Med Commun; 1987 Oct; 8(10):779-86. PubMed ID: 3323960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of IgG subclasses on in vivo bioavailability and metabolic fate of immune-complexed insulin in Lewis rats.
    Arquilla ER; Stenger D; McDougall B; Ulich TR
    Diabetes; 1987 Oct; 36(10):1144-51. PubMed ID: 3308585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scintigraphic distribution of complexes of antiinsulin antibodies and 123I-insulin. In vivo studies in rats.
    Sodoyez-Goffaux F; Sodoyez JC; Koch M; Dozio N; Arquilla ER; McDougall B; De Vos CJ; von Frenckell R
    J Clin Invest; 1987 Aug; 80(2):466-74. PubMed ID: 3301901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoglycemia due to serum-complexed insulin in a patient with diabetes mellitus.
    Albert SG; Popp DA
    Diabetes Care; 1984; 7(3):285-90. PubMed ID: 6428841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship of soluble immune complexes, insulin antibodies and insulin-anti-insulin complexes to platelet and coagulation factors in type 1 diabetic patients with and without proliferative retinopathy.
    Di Mario U; Borsey DQ; Contreas G; Prowse CV; Clarke BF; Andreani D
    Clin Exp Immunol; 1986 Jul; 65(1):57-65. PubMed ID: 2947762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Circulating immune complexes and insulin-binding capacity of the serum of diabetics].
    Vel'bri SK; Lilleorg AL; Kerge IaKh
    Probl Endokrinol (Mosk); 1986; 32(2):25-8. PubMed ID: 3520540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo imaging and quantitative analysis of insulin-receptor interaction in lean and obese Zucker rats.
    Sodoyez JC; Sodoyez-Goffaux F; Treves S; Kahn CR; von Frenckell R
    Diabetologia; 1984 Mar; 26(3):229-33. PubMed ID: 6370772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transplacental passage of insulin in pregnant women with insulin-dependent diabetes mellitus. Its role in fetal macrosomia.
    Menon RK; Cohen RM; Sperling MA; Cutfield WS; Mimouni F; Khoury JC
    N Engl J Med; 1990 Aug; 323(5):309-15. PubMed ID: 2195347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiinsulin receptor antibodies in an insulin-dependent diabetic may arise as autoantiidiotypes.
    Shoelson SE; Marshall S; Horikoshi H; Kolterman OG; Rubenstein AH; Olefsky JM
    J Clin Endocrinol Metab; 1986 Jul; 63(1):56-61. PubMed ID: 3486878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of iodination site on binding of radiolabeled ligand by insulin antibodies and insulin autoantibodies.
    Diaz JL; Wilkin TJ
    Clin Chem; 1988 Feb; 34(2):356-9. PubMed ID: 2449302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin antibodies and hypoglycemia in diabetic patients. Can a quantitative analysis of antibody binding predict the risk of hypoglycemia?
    Kim MR; Sheeler LR; Mansharamani N; Haug MT; Faiman C; Gupta MK
    Endocrine; 1997 Jun; 6(3):285-91. PubMed ID: 9368685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Labelling of interleukin-2 (IL-2) with 123-iodine with retention of its capacity to bind to activated lymphocytes.
    Signore A; Beverley PC; Parman A; Negri M; Pozzilli P
    Exp Clin Endocrinol; 1987 Aug; 89(3):301-6. PubMed ID: 3499331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic 123I-insulin binding kinetics in non-insulin-dependent (type 2) diabetic patients after i.v. bolus administration.
    Oolbekkink M; Heine RJ; den Hollander W; Nauta JJ; van der Veen EA
    Eur J Nucl Med; 1989; 15(6):292-5. PubMed ID: 2670569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.